Trial Details
COMPLETEDBasic Information
| Clinical ID | c3953 |
|---|---|
| Identifier | NCT01277666 |
| Trial Title | A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: GSK1605786A|DRUG: GSK1605786A|DRUG: Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Little Rock |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2010-12-20 |
|---|---|
| Primary Completion Date | 2013-07-11 |
| Completion Date | 2013-07-11 |